TY - JOUR
T1 - Role of Cardiac CT in Pre-Procedure Planning for Transcatheter Mitral Valve Replacement
AU - Ge, Yin
AU - Gupta, Sumit
AU - Fentanes, Emilio
AU - Aghayev, Ayaz
AU - Steigner, Michael
AU - Sobieszczyk, Piotr
AU - Kaneko, Tsuyoshi
AU - Di Carli, Marcelo F.
AU - Bhatt, Deepak L.
AU - Shah, Pinak
AU - Blankstein, Ron
N1 - Publisher Copyright:
© 2021 American College of Cardiology Foundation
PY - 2021/8
Y1 - 2021/8
N2 - Objectives: This study sought to evaluate cardiac computed tomography (CCT) findings and their clinical impact among patients being considered for transcatheter mitral valve replacement (TMVR). Background: CCT is used to evaluate whether patients are candidates for TMVR, but limited data exist on the yield of such tests. Methods: Patients referred for pre-procedural CCT for TMVR planning in the context of failing mitral bioprosthetic valves, annuloplasty rings, and severe native valve disease with annular calcification were included in this study. CCT findings were analyzed to evaluate for suitability for TMVR. In the subset of patients who underwent TMVR, echocardiographic and procedural characteristics were recorded. Results: Among 80 patients who underwent pre-procedural CCT, the mean age was 71.8 ± 11.4 years, 60% were women, and the mean Society of Thoracic Surgeon score was 9.4 ± 6.7. Most cases were referred for valve-in-native annular calcification planning (n = 43), followed by valve-in-valve (n = 29), and valve-in-ring procedures (n = 8). A total of 51 (64%) patients did not undergo TMVR, 37 of whom had high-risk features identified on CCT. The most common reason for exclusion was related to large annular size, followed by heightened risk of left ventricular outflow tract (LVOT) obstruction. Among 29 patients (36%) who underwent TMVR, the 30-day mortality rate was 17%. Five patients experienced LVOT obstruction, 4 of whom were predicted by CCT. Following TMVR, 5 patients had at least moderate peri-valvular regurgitation. Conclusions: A minority of patients referred for TMVR planning ultimately undergo the procedure. CCT identifies unsuitable anatomy and leads to exclusion in a significant number of cases.
AB - Objectives: This study sought to evaluate cardiac computed tomography (CCT) findings and their clinical impact among patients being considered for transcatheter mitral valve replacement (TMVR). Background: CCT is used to evaluate whether patients are candidates for TMVR, but limited data exist on the yield of such tests. Methods: Patients referred for pre-procedural CCT for TMVR planning in the context of failing mitral bioprosthetic valves, annuloplasty rings, and severe native valve disease with annular calcification were included in this study. CCT findings were analyzed to evaluate for suitability for TMVR. In the subset of patients who underwent TMVR, echocardiographic and procedural characteristics were recorded. Results: Among 80 patients who underwent pre-procedural CCT, the mean age was 71.8 ± 11.4 years, 60% were women, and the mean Society of Thoracic Surgeon score was 9.4 ± 6.7. Most cases were referred for valve-in-native annular calcification planning (n = 43), followed by valve-in-valve (n = 29), and valve-in-ring procedures (n = 8). A total of 51 (64%) patients did not undergo TMVR, 37 of whom had high-risk features identified on CCT. The most common reason for exclusion was related to large annular size, followed by heightened risk of left ventricular outflow tract (LVOT) obstruction. Among 29 patients (36%) who underwent TMVR, the 30-day mortality rate was 17%. Five patients experienced LVOT obstruction, 4 of whom were predicted by CCT. Following TMVR, 5 patients had at least moderate peri-valvular regurgitation. Conclusions: A minority of patients referred for TMVR planning ultimately undergo the procedure. CCT identifies unsuitable anatomy and leads to exclusion in a significant number of cases.
KW - LVOT obstruction
KW - TMVR
KW - cardiac CT
UR - http://www.scopus.com/inward/record.url?scp=85104988721&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2020.12.018
DO - 10.1016/j.jcmg.2020.12.018
M3 - Article
C2 - 33865768
AN - SCOPUS:85104988721
SN - 1936-878X
VL - 14
SP - 1571
EP - 1580
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 8
ER -